Amyris Inc Third Virtual Investor Mini-Series Webinar Transcript
Good morning, and welcome to Part 3 of the Amyris event series, delivering on the promise of synthetic biology. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Han Kieftenbeld, Chief Financial and Chief Administration Officer of Amyris. Please go ahead.
Thank you, Andrew, and good morning and good afternoon, everyone. With me today from Amyris are John Melo, President and Chief Executive Officer; Eduardo Alvarez, Chief Operating Officer; Annie Tsong, Senior Director, Product Innovation; and our guest, Fernando Queiroz, Chief Executive Officer of Minerva Foods.
Today's webcast is the third session in the Amyris Virtual Investor miniseries after very well-attended sessions on December 15 and February 9.
The theme for the series is delivering on the promise of synthetic biology. Today, we will feature our ingredients portfolio with the title, Science and Partnerships, Building Blocks for Disruptive,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |